Zimmer Biomet Holdings Inc.ZBH
Health Care · Health Care Equipment & Services · NYSE · United States · zimmerbiomet.com
Zimmer Biomet Holdings, Inc. is a global medical device company specializing in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, spine implants, sports medicine and biologics, dental implants, and related surgical products, serving surgeons and patients in more than 100 countries.
Key ratios
Operating cash flow growth
4.8%TTM
2025
13.2%2024
-5.2%2023
23.1%
EPS growth
0.2%TTM
2025
-19.9%2024
-9.2%2023
253.6%
FCF / Sales
14.1%TTM
2025
14.2%2024
13.7%2023
13.2%
Net margin
9.5%TTM
2025
8.6%2024
11.8%2023
13.9%
ROA
3.9%TTM
2025
3.9%2024
4.7%2023
4.4%
ROE
5.6%TTM
2025
5.6%2024
7.3%2023
8.4%
Revenue growth
8.6%TTM
2025
7.2%2024
3.9%2023
6.6%
Recent news
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End
Zimmer Biomet Announces First Quarter 2026 Financial Results
Track ZBH in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer